Feedback / Questions
NRTX-1001 - Neurona Therap
https://www.globenewswire.com/news-release/2025/06/18/3101388/0/en/Neurona-Doses-First-Patient-in-Phase-1-2-Trial-of-NRTX-1001-Cell-Therapy-in-Adults-with-Drug-Resistant-Bilateral-Mesial-Temporal-Lobe-Epilepsy-MTLE.html
Jun 18, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next